CLDI Calidi Biotherapeutics, Inc.
NYSE · SEC CIK 1855485 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1,241 1 sales by 1 insiders
- Filings on record
- 53 since 2022-09-14, latest 2026-08-19 19:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Camaisa Allan | Dir | — | $1,241 |
Transactions 26
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-12-16 | 2025-12-12 | CLDI | Camaisa Allan | Dir | S - Sale | $1.46 | -850 | 77.0K | -1% | -$1,241 |
| D | 2025-08-25 | 2025-08-21 | CLDI | Poma Eric E | CEO, Dir | P - Purchase | $2.00 | +25.0K | 25.0K | New | +$50.0K |
| D | 2025-08-25 | 2025-08-21 | CLDI | Leftwich Scott | Dir | P - Purchase | $2.00 | +125.0K | 130.7K | +2,212% | +$250.0K |
| D | 2025-08-25 | 2025-08-21 | CLDI | Schoeneck James A | Dir | P - Purchase | $2.00 | +75.0K | 76.1K | +6,614% | +$150.0K |
| D | 2025-08-25 | 2025-08-21 | CLDI | Jackson Andrew C. | CFO | P - Purchase | $2.00 | +2,500 | 2,500 | New | +$5,000 |
| 2025-01-03 | 2024-12-31 | CLDI | Leftwich Scott | Dir | A - Grant | — | +11.7K | 67.8K | +21% | — | |
| 2025-01-03 | 2024-12-31 | CLDI | Stewart Alan R. | Dir | A - Grant | — | +12.8K | 29.0K | +79% | — | |
| 2024-12-18 | 2024-12-17 | CLDI | Camaisa Allan | CEO, COB, Dir | S - Sale | $1.62 | -10.0K | 66.7K | -13% | -$16.2K | |
| 2024-09-30 | 2024-09-26 | CLDI | Camaisa Allan | CEO, COB, Dir, 10% | A - Grant | $1.15 | +70.2K | 76.7K | +1,070% | +$80.7K | |
| 2024-07-02 | 2024-03-29 | CLDI | Leftwich Scott | Dir | A - Grant | — | +23.8K | 493.7K | +5% | — | |
| 2024-07-02 | 2024-03-29 | CLDI | Stewart Alan R. | Dir | A - Grant | — | +26.0K | 80.7K | +48% | — | |
| 2024-07-02 | 2024-06-28 | CLDI | Stewart Alan R. | Dir | A - Grant | — | +73.4K | 154.1K | +91% | — | |
| 2024-07-02 | 2024-06-28 | CLDI | Schoeneck James A | Dir | A - Grant | — | +79.7K | 1.07M | +8% | — | |
| 2024-07-02 | 2024-03-29 | CLDI | Schoeneck James A | Dir | A - Grant | — | +28.2K | 992.1K | +3% | — | |
| 2024-07-02 | 2024-06-28 | CLDI | Leftwich Scott | Dir | A - Grant | — | +67.2K | 560.9K | +14% | — | |
| DMI | 2024-06-05 | 2024-06-03 | CLDI | Schoeneck James A | Dir | M - OptEx | $0.2 | +548.0K | 588.9K | +1,340% | +$109.6K |
| DI | 2024-04-22 | 2024-04-18 | CLDI | Schoeneck James A | Dir | A - Grant | $0.4 | +375.0K | 415.9K | +917% | +$150.0K |
| D | 2024-01-04 | 2023-12-21 | CLDI | Schoeneck James A | Dir | A - Grant | $1.80 | +10.6K | 27.9K | +62% | +$19.1K |
| 2024-01-04 | 2023-12-21 | CLDI | Zulueta Alfonso G | Dir | A - Grant | $1.80 | +5,644 | 133.3K | +4% | +$10.2K | |
| D | 2024-01-04 | 2023-12-21 | CLDI | Leftwich Scott | Dir | A - Grant | $1.80 | +8,958 | 469.9K | +2% | +$16.1K |
| 2024-01-04 | 2023-12-21 | CLDI | Stewart Alan R. | Dir | A - Grant | $1.80 | +7,282 | 54.7K | +15% | +$13.1K | |
| 2023-12-26 | 2023-12-21 | CLDI | Vecchiolla Thomas A. | Dir | A - Grant | $1.80 | +7,709 | 365.1K | +2% | +$13.9K | |
| I | 2023-09-14 | 2023-09-12 | CLDI | Hudson Bay Capital Management LP | 10% | J - Other | $10.49 | -500.0K | 0 | -100% | -$5.25M |
| DI | 2023-09-14 | 2023-09-12 | CLDI | FLAG Sponsor Manager, LLC | 10% | C - Cnv Deriv | — | +1.93M | 1.93M | New | — |
| D | 2023-09-14 | 2023-09-12 | CLDI | Vecchiolla Thomas A. | Dir | C - Cnv Deriv | — | +6,000 | 6,000 | New | — |
| I | 2022-10-21 | 2022-10-19 | CLDI | Polar Asset Management Partners Inc. | 10% | S - Sale | $9.90 | -36.2K | 412.8K | -8% | -$358.4K |
Purchase Sale Sale after option exercise All abbreviations